Barclays Initiates Coverage of Olin at Equal-Weight

Fintel reports that on October 13, 2026, Barclays initiated coverage of Olin (NYSE:OLN) (BRSE:OLN) with a Equal-Weight recommendation.

Olin Corporation, based in the United States, is a leading manufacturer in the chemical industry, specializing particularly in the production of chlorine and sodium hydroxide, essential chemicals used in a wide range of industrial and consumer products. The company operates through three major divisions: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. Each division targets different markets, with Winchester focusing on ammunition, an area seeing significant demand particularly in the sports shooting market. Olin's strategic operations emphasize sustainability and technological advancements in chemical manufacturing, alongside a robust commitment to safety and environmental stewardship. This commitment is integral as the company seeks to expand its market reach and enhance operational efficiencies across its global network.

Prior to this rating action, Olin's stock closed at $14.71 on October 12, 2026. This latest close represents a price change of -9.59% over one week, compared to a baseline close of $16.27 on October 5, 2026. Over a one-month period, the stock experienced a price change of -14.48% from a baseline close of $17.20 on September 11, 2026.

Separately from Barclays' individual rating, the current consensus target price for Olin was $20.90 as of October 2, 2026, representing an implied change of +42.06% from the stock's recent levels. This current consensus target mean is down from a prior consensus target mean of $22.20 on September 15, 2026, which reflects a consensus target revision of -5.89%. The current consensus target median was recorded at $20.40 on October 2, 2026. In terms of aggregate analyst recommendations, the current recommendation period as of September 1, 2026, shows a total of 20 recommendations, consisting of 0 strong buy, 1 buy, 13 hold, 5 sell, and 1 strong sell ratings. This represents a positive percentage of 5.0%, a hold percentage of 65.0%, and a negative percentage of 30.0%. In comparison, the prior recommendation period as of August 1, 2026, had a total of 17 recommendations, with 1 strong buy, 4 buy, 11 hold, 1 sell, and 0 strong sell ratings, representing a positive percentage of 29.4%, a hold percentage of 64.7%, and a negative percentage of 5.9%.

Olin's latest earnings report was released on July 30, 2026, showing an actual EPS of 0.07 against an estimate of 0.1018, which represents an EPS surprise of -31.24%. The company reported actual revenue of $1,741,900,000.00, compared to an estimated revenue of $1,825,564,122.00. The upcoming earnings date is scheduled for October 29, 2026, during the amc session. On the same day as Barclays' initiation, October 13, 2026, RBC Capital also maintained its Sector Perform rating on Olin. Other recent analyst actions include UBS maintaining a Neutral rating on October 5, 2026, Wells Fargo maintaining an Equal-Weight rating on October 1, 2026, and Citigroup maintaining a Neutral rating on September 30, 2026, after previously reiterating a Neutral rating on September 15, 2026.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.